TP53 and neoplasm: Of these 3 tumors, T1238 and T738 also have reduced CDKN2A expression (Z-score: − 0.69, − 0.65), while tumor T416 bears a TP53 missense mutation and RB1 CNV loss (Supplementary Fig. S13).